Goodwin Procter Expands IP Litigation Group

September 8, 2014- Goodwin Procter announced today that five attorneys have joined as partners in the firm’s Intellectual Property Litigation Practice. They come to Goodwin from Kenyon & Kenyon, a specialty intellectual property firm known for litigating high-stakes patent cases.

“We are delighted that this distinguished and talented group has chosen Goodwin as the firm that best complements their respected intellectual property practices”

Joining Goodwin Procter in New York are Elizabeth J. Holland, Robert V. Cerwinski, Huiya Wu, and Cynthia Lambert Hardman, and joining in Washington, D.C. is William G. James. The group has significant patent litigation experience relating to pharmaceuticals, biotechnology and other life sciences, as well as Hatch-Waxman ANDA litigation, trade secret and ITC litigation, and inter partes review at the U.S. Patent & Trademark Office.

“We are delighted that this distinguished and talented group has chosen Goodwin as the firm that best complements their respected intellectual property practices,” said Regina M. Pisa, chairman of Goodwin Procter. “Their arrival gives our clients a distinct advantage when facing intellectual property challenges and related matters in an increasingly complex marketplace.”

Elizabeth Holland is an experienced trial lawyer focusing exclusively on patent infringement and related litigation. With more than 25 years’ experience, she has litigated patents in a wide array of technical areas and industries, including those involving pharmaceutical, chemical, medical device, and consumer products. She has particular expertise in Hatch-Waxman litigation, having tried numerous cases in this area on behalf of both branded and generic drug companies. She chaired Kenyon & Kenyon’s Diversity Committee and was the first woman to serve on its Management Committee.

William James, who also served on Kenyon’s Management Committee, focuses his practice on patent litigation related to pharmaceutical and biotechnology products. He has significant experience with Hatch-Waxman litigations, representing both plaintiffs and defendants, including first-to-file cases and multi-defendant ANDA drug challenges. He also advises pharmaceutical and biotechnology companies on freedom-to-operate, due diligence, licensing, and prosecution issues.

Robert Cerwinski has extensive experience litigating intellectual property matters. For more than a decade, he has successfully represented both plaintiffs and defendants in patent and trade secret litigation before federal and state courts across the country. His primary focus is on litigation involving pharmaceutical and biological products.

Huiya Wu has practiced intellectual property law for over a decade, focusing on patent and related litigation. She represents both plaintiffs and defendants before federal district and state courts, as well as before the International Trade Commission. She handles all phases of U.S. patent litigation, including pre-trial investigation, fact and expert discovery, and motion, trial and appellate practice.

Cynthia Hardman has over a decade of experience litigating complex intellectual property cases, from developing initial strategy through appeal. She appears in cases before federal district courts, the U.S. Court of Appeals for the Federal Circuit and the International Trade Commission, and represents clients in the pharmaceutical, medical device, nutritional supplement, and consumer product industries.

“Our group is excited to join Goodwin Procter, ” said Elizabeth Holland. “We believe that Goodwin’s first-rate IP litigation team combined with the firm’s full-service capabilities will provide us an outstanding platform from which to serve our clients.”

“We have known Elizabeth and her colleagues for some time, and we are thrilled to have attracted such a strong group of IP litigators,” said Douglas Kline, chairman of Goodwin’s IP Litigation Group. “They are excellent lawyers who will join a team committed to delivering outstanding service to the pharmaceutical and biotechnology sectors.”

Goodwin Procter’s Patent Litigation Practice is ranked by Corporate Counsel as one of the nation’s most active patent litigation practices, drawing on the firm’s more than 150 IP attorneys and scientists dedicated to actively protecting and promoting client assets. Goodwin routinely works with clients to take cases from pre-suit investigations through discovery proceedings and trials and its attorneys provide counsel on infringement, validity and patentability issues, and when necessary, litigate patents in federal district courts throughout the country. The firm has substantial experience before the Federal Circuit, the International Trade Commission, the Patent Trial and Appeal Board, and the U.S. Court of Federal Claims.

About Goodwin Procter

Goodwin Procter LLP is a leading Am Law 50 and Global 100 law firm, with offices in Boston, Hong Kong, London, Los Angeles, New York, San Francisco, Silicon Valley and Washington, D.C. The firm provides corporate law and litigation services, with a focus on matters involving real estate, REITs and real estate capital markets; private equity; technology and life sciences companies; financial institutions; intellectual property; products liability and mass torts; and securities litigation and white collar defense. Information may be found at www.goodwinprocter.com. Follow us on Twitter@goodwinprocter.